0000000000345117
AUTHOR
Blanca Trejo-velasco
Mean velocity of the pulmonary artery estimated by cardiac magnetic resonance as an early prognostic predictor in heart failure.
Background and objective: To identify early, non-invasive prognostic indicators in heart failure (HF), with and without associated pulmonary hypertension, by means of cardiac magnetic resonance, and oxidative stress and anti-inflammatory biomarkers such as Trolox (TM) (antioxidant status) and IL-10 (anti-inflammatory cytokine). Patients and methods: We prospectively included 70 patients admitted for new-onset HF. During index admission, mean velocity of the pulmonary artery (mvPA) was measured, and blood Trolox (TM) and IL-10 determined. The study sample was divided in two groups according to the optimal cut-off value for event prediction calculated by the ROC curve (mvPA = 8 cm/s), conside…
Prognostic role of tapse to pasp ratio in patients undergoing mitraclip procedure
Producción Científica
Transcatheter Mitral Repair for Functional Mitral Regurgitation According to Left Ventricular Function: A Real-Life Propensity-Score Matched Study
Background: Transcatheter mitral valve repair (TMVR) could improve survival in functional mitral regurgitation (FMR), but it is necessary to consider the influence of left ventricular ejection fraction (LVEF). Therefore, we compare the outcomes after TMVR with Mitraclip®
Velocidad media de la arteria pulmonar estimada por resonancia magnética cardiaca como predictor pronóstico precoz en insuficiencia cardiaca
Resumen Introduccion y objetivo La hipertension pulmonar asocia peor pronostico en insuficiencia cardiaca (IC). En este estudio buscamos identificar predictores pronosticos no invasivos en IC con y sin hipertension pulmonar asociada, mediante resonancia magnetica cardiaca y determinacion de marcadores de estres oxidativo y antiinflamatorios. Pacientes y metodos Inclusion prospectiva de 70 pacientes ingresados por IC de comienzo, en los que se determino la velocidad media de arteria pulmonar (vmAP) y la concentracion sanguinea de TroloxTM (estatus antioxidante) e IL-10 (citocina antiinflamatoria). La muestra se dividio en dos grupos de acuerdo con el valor optimo de vmAP para la prediccion d…